Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

innospec inc. - IOSP

IOSP

Close Chg Chg %
78.12 0.28 0.36%

Closed Market

78.40

+0.28 (0.36%)

Volume: 83.06K

Last Updated:

Dec 26, 2025, 4:00 PM EDT

Trade Now

Company Overview: innospec inc. - IOSP

IOSP Key Data

Open

$77.83

 Day Range

77.35 - 78.64

52 Week Range

70.10 - 116.89

 Market Cap

$1.94B

Shares Outstanding

24.78M

 Public Float

24.44M

Beta

0.92

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$0.05

Yield

218.89%

 Dividend

$0.87

EX-DIVIDEND DATE

Nov 18, 2025

 SHORT INTEREST

N/A

AVERAGE VOLUME

272.91K

  

IOSP Performance

1 Week
 
 0.99%
 
1 Month
 
 4.87%
 
3 Months
 
 1.11%
 
1 Year
 
 -29.15%
 
5 Years
 
 -13.59%
 

IOSP Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 3
Full Ratings ➔

About innospec inc. - IOSP

Innospec, Inc. engages in the development, manufacture, blend, marketing, and supply of fuel additives, oilfield chemicals, personal care, and other specialty chemicals. It operates through the following segments: Fuel Specialties, Performance Chemicals, and Oilfield Services. The Fuel Specialties segment develops, manufactures, blends, markets, and supplies a range of specialty chemical products used as additives to a range of fuels. The Performance Chemicals segment provides technology-based solutions for customers processes or products focused on the personal care, home care, agrochemical, and mining industries. The Oilfield Services segment refers to the development and marketing of chemical solutions for fracturing, drilling, stimulation, completion operations, products for oil and gas production, and transport. The company was founded in 1938 and is headquartered in Englewood, CO.

IOSP At a Glance

Innospec, Inc.
8310 South Valley Highway
Englewood, Colorado 80112
Phone 1-303-792-5554 Revenue 1.85B
Industry Chemicals: Major Diversified Net Income 35.60M
Sector Process Industries Employees 2,450
Fiscal Year-end 12 / 2025
View SEC Filings

IOSP Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 77.66
Price to Sales Ratio 1.498
Price to Book Ratio 2.268
Price to Cash Flow Ratio 15.01
Enterprise Value to EBITDA 11.008
Enterprise Value to Sales 1.368
Total Debt to Enterprise Value 0.018

IOSP Efficiency

Revenue/Employee 753,224.49
Income Per Employee 14,530.612
Receivables Turnover 5.401
Total Asset Turnover 1.072

IOSP Liquidity

Current Ratio 2.576
Quick Ratio 1.765
Cash Ratio 0.779

IOSP Profitability

Gross Margin 28.861
Operating Margin 9.814
Pretax Margin 2.233
Net Margin 1.929
Return on Assets 2.069
Return on Equity 3.019
Return on Total Capital 2.834
Return on Invested Capital 2.941

IOSP Capital Structure

Total Debt to Total Equity 3.707
Total Debt to Total Capital 3.575
Total Debt to Total Assets 2.588
Long-Term Debt to Equity 2.559
Long-Term Debt to Total Capital 2.468
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Innospec Inc. - IOSP

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
1.48B 1.96B 1.95B 1.85B
Sales Growth
+24.33% +32.38% -0.76% -5.31%
Cost of Goods Sold (COGS) incl D&A
1.06B 1.39B 1.37B 1.31B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
46.20M 45.00M 47.40M 48.30M
Depreciation
30.20M 31.00M 36.80M 35.70M
Amortization of Intangibles
16.00M 14.00M 10.60M 12.60M
COGS Growth
+22.32% +30.74% -1.63% -3.89%
Gross Income
421.20M 575.00M 582.80M 532.60M
Gross Income Growth
+29.72% +36.51% +1.36% -8.61%
Gross Profit Margin
+28.39% +29.28% +29.91% +28.86%
2021 2022 2023 2024 5-year trend
SG&A Expense
290.90M 387.70M 418.10M 351.50M
Research & Development
37.40M 38.70M 41.70M 47.80M
Other SG&A
253.50M 349.00M 376.40M 303.70M
SGA Growth
+16.41% +33.28% +7.84% -15.93%
Other Operating Expense
- - - -
-
Unusual Expense
(1.00M) (700.00K) 7.10M 153.70M
EBIT after Unusual Expense
131.30M 188.00M 157.60M 27.40M
Non Operating Income/Expense
4.60M (2.30M) 16.80M 13.80M
Non-Operating Interest Income
- - 2.30M 9.30M
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - 1.50M 1.10M
-
Interest Expense Growth
- - -16.67% -26.67%
-
Gross Interest Expense
- - 1.50M 1.10M
-
Interest Capitalized
- - - -
-
Pretax Income
134.40M 184.60M 174.40M 41.20M
Pretax Income Growth
+238.54% +37.35% -5.53% -76.38%
Pretax Margin
+9.06% +9.40% +8.95% +2.23%
Income Tax
41.30M 51.60M 35.30M 5.60M
Income Tax - Current - Domestic
15.00M 33.50M 12.60M 19.80M
Income Tax - Current - Foreign
19.40M 23.10M 18.60M 26.20M
Income Tax - Deferred - Domestic
(2.20M) (4.40M) 5.50M (4.60M)
Income Tax - Deferred - Foreign
9.10M (600.00K) (1.40M) (35.80M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
93.10M 133.00M 139.10M 35.60M
Minority Interest Expense
- - - -
-
Net Income
93.10M 133.00M 139.10M 35.60M
Net Income Growth
+224.39% +42.86% +4.59% -74.41%
Net Margin Growth
+6.28% +6.77% +7.14% +1.93%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
93.10M 133.00M 139.10M 35.60M
Preferred Dividends
- - - -
-
Net Income Available to Common
93.10M 133.00M 139.10M 35.60M
EPS (Basic)
3.7773 5.3657 5.5974 1.4279
EPS (Basic) Growth
+223.29% +42.05% +4.32% -74.49%
Basic Shares Outstanding
24.65M 24.79M 24.85M 24.93M
EPS (Diluted)
3.7459 5.3238 5.5591 1.4172
EPS (Diluted) Growth
+223.42% +42.12% +4.42% -74.51%
Diluted Shares Outstanding
24.85M 24.98M 25.02M 25.12M
EBITDA
176.50M 232.30M 212.10M 229.40M
EBITDA Growth
+40.64% +31.61% -8.70% +8.16%
EBITDA Margin
+11.90% +11.83% +10.88% +12.43%

Snapshot

Average Recommendation BUY Average Target Price 102.667
Number of Ratings 3 Current Quarters Estimate 1.25
FY Report Date 12 / 2025 Current Year's Estimate 5.047
Last Quarter’s Earnings 1.12 Median PE on CY Estimate N/A
Year Ago Earnings 5.92 Next Fiscal Year Estimate 5.67
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 3 2 3 3
Mean Estimate 1.25 1.32 5.05 5.67
High Estimates 1.28 1.35 5.05 5.85
Low Estimate 1.23 1.29 5.04 5.56
Coefficient of Variance 2.12 3.21 0.11 2.77

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 3 3 2
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Innospec Inc. - IOSP

Date Name Shares Transaction Value
Feb 28, 2025 Elizabeth Keller Arnold Director 4,837 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 28, 2025 Hardy Louis Iii Griffin SVP, HUMAN RESOURCES N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 28, 2025 Hardy Louis Iii Griffin SVP, HUMAN RESOURCES 7,342 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 28, 2025 Hardy Louis Iii Griffin SVP, HUMAN RESOURCES 5,660 Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $101.99 per share 577,263.40
Feb 28, 2025 Hardy Louis Iii Griffin SVP, HUMAN RESOURCES 5,781 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $99.68 per share 576,250.08
Feb 28, 2025 Corbin Barnes SVP, Corporate Dev and IR N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 28, 2025 Corbin Barnes SVP, Corporate Dev and IR 9,738 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 28, 2025 Corbin Barnes SVP, Corporate Dev and IR 8,051 Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $101.99 per share 821,121.49
Feb 28, 2025 Corbin Barnes SVP, Corporate Dev and IR 8,251 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $99.68 per share 822,459.68
Feb 28, 2025 Graeme Blair Head of Group Finance 300 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 28, 2025 Leslie J. Parrette Director 5,943 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 28, 2025 Lawrence J. Padfield Director 8,508 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 28, 2025 Claudia P. Poccia Director 5,088 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 28, 2025 Milton C. Blackmore Director 9,585 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 28, 2025 Ian Philip Cleminson VP & CFO 20,133 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 28, 2025 Patrick S. Williams PRESIDENT & CEO 212,412 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 28, 2025 David Farrington Landless Director 6,687 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 28, 2025 David Bentley Jones SVP, GC & CCO 11,700 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 28, 2025 Ian Malcolm McRobbie Senior VP R&T 1,560 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Innospec Inc. in the News